Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aged 18 Years or Older”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Large-scale testing (Phase 3)Ended earlyNCT05643573
What this trial is testing

Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke

Who this might be right for
Prevention of Stroke or Systemic EmbolismAtrial Fibrillation
Bayer 14,830
Large-scale testing (Phase 3)Study completedNCT03379727
What this trial is testing

Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 301
Large-scale testing (Phase 3)Ended earlyNCT05683600
What this trial is testing

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 3,000
Not applicableStudy completedNCT01384370
What this trial is testing

APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results

Who this might be right for
Human Papillomavirus Infection
Gen-Probe, Incorporated 1,260
Testing effectiveness (Phase 2)Active Not RecruitingNCT06206837
What this trial is testing

Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Pfizer 71
Large-scale testing (Phase 3)UnknownNCT05602558
What this trial is testing

The Phase Ⅱ/Ⅲ Trial of LYB001

Who this might be right for
COVID-19
Yantai Patronus Biotech Co., Ltd. 18,000
Not applicableNot Yet RecruitingNCT07371039
What this trial is testing

Sacral Pressure During Labor: Effects on Pain and Maternal Satisfaction

Who this might be right for
Getting PregnantLabor PainIntrapartum Period+3 more
Izmir Kavram Vocational School 60
Large-scale testing (Phase 3)Study completedNCT05540522
What this trial is testing

Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older

Who this might be right for
Influenza, Human
Pfizer 45,789
Not applicableUnknownNCT03243877
What this trial is testing

Performance of MammoAlert™, Point of Care System, for the Screening of Breast Cancer in Women 18 Years of Age or Older

Who this might be right for
Breast Cancer
POC Medical Systems, Inc. 2,458
Testing effectiveness (Phase 2)WithdrawnNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Q32 Bio Inc.
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Testing effectiveness (Phase 2)Study completedNCT04568031
What this trial is testing

Study of AZD1222 for the Prevention of COVID-19 in Japan

Who this might be right for
COVID-19
AstraZeneca 256
Not applicableUnknownNCT05745545
What this trial is testing

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 3,200
Large-scale testing (Phase 3)Active Not RecruitingNCT04636697
What this trial is testing

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

Who this might be right for
SARS-CoV-2 Infection
Medicago 30,918
Early research (Phase 1)Ended earlyNCT06580938
What this trial is testing

Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer

Who this might be right for
Non Small Cell Lung CancerBladder CancerRenal Cell Carcinoma+3 more
Pfizer 4
Large-scale testing (Phase 3)Study completedNCT05686070
What this trial is testing

Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

Who this might be right for
Prevention of Ischemic StrokeAcute Non-cardioembolic Ischemic StrokeHigh-risk Transient Ischemic Attack
Bayer 12,327
Testing effectiveness (Phase 2)UnknownNCT05865041
What this trial is testing

Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants

Who this might be right for
Alopecia Areata
ASLAN Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT03814590
What this trial is testing

Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,053
Large-scale testing (Phase 3)Study completedNCT05047770
What this trial is testing

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,013
Early research (Phase 1)Study completedNCT06237296
What this trial is testing

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy VolunteersMetapneumovirus Infection
Sanofi Pasteur, a Sanofi Company 558
Load More Results